One study showed that serum GDF15 was elevated in patients following subarachnoid haemorrhage, and this elevation in the first 9 days related to worsened primary and secondary neurological outcomes at 90 day follow up (106). This evidence concerns the gene GDF15 and subarachnoid hemorrhage.